ECSP992929A - SUBSTITUTED TRICYCLIC COMPOUNDS (CASE X-12143) - Google Patents
SUBSTITUTED TRICYCLIC COMPOUNDS (CASE X-12143)Info
- Publication number
- ECSP992929A ECSP992929A ECSP992929A ECSP992929A EC SP992929 A ECSP992929 A EC SP992929A EC SP992929 A ECSP992929 A EC SP992929A EC SP992929 A ECSP992929 A EC SP992929A
- Authority
- EC
- Ecuador
- Prior art keywords
- case
- tricyclic compounds
- substituted tricyclic
- compounds
- substituted
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 102000005473 Secretory Phospholipases A2 Human genes 0.000 abstract 1
- 108010031873 Secretory Phospholipases A2 Proteins 0.000 abstract 1
- 206010040070 Septic Shock Diseases 0.000 abstract 1
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 1
- 229930195729 fatty acid Natural products 0.000 abstract 1
- 239000000194 fatty acid Substances 0.000 abstract 1
- 150000004665 fatty acids Chemical class 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 230000036303 septic shock Effects 0.000 abstract 1
Landscapes
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
Se describen una clase de nuevos compuestos tricíclicos junto con el uso de tales compuestos para inhibir la liberación de ácidos grasos mediada por sPLA2 para el tratamiento de afecciones como el choque séptico.A class of novel tricyclic compounds are described in conjunction with the use of such compounds to inhibit sPLA2-mediated fatty acid release for the treatment of conditions such as septic shock.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP992929 ECSP992929A (en) | 1999-04-16 | 1999-04-16 | SUBSTITUTED TRICYCLIC COMPOUNDS (CASE X-12143) |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP992929 ECSP992929A (en) | 1999-04-16 | 1999-04-16 | SUBSTITUTED TRICYCLIC COMPOUNDS (CASE X-12143) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP992929A true ECSP992929A (en) | 2000-01-27 |
Family
ID=42043919
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP992929 ECSP992929A (en) | 1999-04-16 | 1999-04-16 | SUBSTITUTED TRICYCLIC COMPOUNDS (CASE X-12143) |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP992929A (en) |
-
1999
- 1999-04-16 EC ECSP992929 patent/ECSP992929A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2179088T3 (en) | FLSA2 INHIBITORS 1H-INDOL-3-GLIOXYLAMIDE. | |
| BR9901279A (en) | Replaced tricycles | |
| PA8593001A1 (en) | PIRIMIDINE DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELLULAR GROWTH | |
| UY26186A1 (en) | METALOPROTEASE INHIBITORS | |
| PA8468401A1 (en) | COMPOUNDS FOR THE TREATMENT OF ISCHEMIA | |
| GT200300201A (en) | NEW ESPIROCONDENSED QUINAZOLINONES AND ITS USE AS PHOSPHODIESTERASE INHIBITORS | |
| GT199900056A (en) | NEW DIHYDROPYRIMIDINES | |
| SK5342002A3 (en) | Tricyclic compounds useful as HIV reverse transcriptase inhibitors | |
| BR9713261A (en) | Tricyclics replaced | |
| GT200000190A (en) | PROCEDURE FOR OBTAINING 1,2,3,4-TETRAHYDROCHINOLINES-4-CARBOXYAMIN-2-SUBSTITUTED. | |
| SV2008002542A (en) | SOLID CRYSTALLINE FORMS OF TIGECICLINE AND METHODS TO PREPARE THE SAME REF. 01142.0379-00267 (AM101946SV) | |
| SV1999000052A (en) | SUBSTITUTED TRICYCLES REF. X-12144 | |
| AR024462A1 (en) | PHARMACEUTICAL TABLETS | |
| ES2159347T3 (en) | NAFTIL-ACETAMIDS AS SPLA2 INHIBITORS. | |
| UY27894A1 (en) | CINAMIDE DERIVATIVES | |
| ES2196813T3 (en) | VITAMIN E AND ESTERS OF THE SAME, FOR USE IN THE TOPICAL TREATMENT OF MUCOSA PATHOLOGIES. | |
| UY29771A1 (en) | NEW CRYSTAL FORM | |
| SE9801494D0 (en) | Novel use | |
| ES2181052T3 (en) | PHENYLACETAMIDS AS INHIBITORS OF SPLA2. | |
| PA8571401A1 (en) | IMIDAZOLINILMETIL ARALQUILSULFONAMIDAS | |
| ES2174034T3 (en) | NAFTILGLIOXAMIDS AS SPLA2 INHIBITORS | |
| AR026209A1 (en) | BASIC MONOCICLIC COMPOUNDS WITH NK-2 ACTION ANTAGONIST, MANUFACTURING PROCESSES AND FORMULAS CONTAINING THEM | |
| ECSP992929A (en) | SUBSTITUTED TRICYCLIC COMPOUNDS (CASE X-12143) | |
| BR0013515A (en) | Fatty Acid Synthase Inhibitors | |
| ECSP992928A (en) | SUBSTITUTED TRICYCLIC COMPOUNDS (CASE X-12144) |